Twin Tree Management, LP Agios Pharmaceuticals, Inc. Transaction History

Twin Tree Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$27.55 - $48.83 $1,432 - $2,539	52 New	52 $2,000
Q4 2020 Feb 12, 2021	SELL	$33.21 - $46.54 $86,744 - $121,562	-2,612 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$33.87 - $55.93 $88,468 - $146,089	2,612 New	2,612 $91,000
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $34,712 - $58,380	-1,154 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$32.4 - $49.58 $37,389 - $57,215	1,154 New	1,154 $37,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.